Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Sio Gene Therapies Inc. | a33116ex311.htm |
| EX-32.2 - EXHIBIT 32.2 - Sio Gene Therapies Inc. | a33116ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Sio Gene Therapies Inc. | a33116ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Sio Gene Therapies Inc. | a33116ex312.htm |
| EX-21.1 - EXHIBIT 21.1 - Sio Gene Therapies Inc. | a33116ex211.htm |
| EX-10.12 - EXHIBIT 10.12 - Sio Gene Therapies Inc. | a33116ex1012.htm |
| 10-K - 10-K - Sio Gene Therapies Inc. | a3311610k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-206300) of Axovant Sciences Ltd. of our report dated June 6, 2016 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, NJ
June 6, 2016
1